PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University College London, Department of Neonatology, United Kingdom. Electronic address: uclqhjh@ucl.ac.uk.\', \'Department of Pharmaceutics, University of Nigeria Nsukka, Nigeria. Electronic address: chinekwu.nwobi@unn.edu.ng.\', \'Department of Internal Medicine, University of Nigeria Teaching Hospital Ituku-Ozalla, Enugu, Nigeria.\', \'Department of Pharmaceutics and Pharmaceutical Technology Enugu State University of Science and Technology, Nigeria. Electronic address: Chinedu.ekweremadu.17@alumni.ucl.ac.uk.\', \'Basildon and Thurrock University Hospital, United Kingdom. Electronic address: san.kim@btuh.nhs.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1567-5769(20)33714-010.1016/j.intimp.2020.107247
?:doi
?:hasPublicationType
?:journal
  • International immunopharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33307513
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.051
?:rankingScore_hIndex
  • 94
?:title
  • COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnology.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all